/A
Agilent Technologies, Inc.
A • NYSEA • NYSE • Healthcare
$112.75+0.82%+0.92
$112.75+0.82%(+0.92)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
68Low Risk
Momentum
17Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
52.4%▼1.9pp
Revenue after COGS
Operating
21.3%▼1.6pp
After operating expenses
Net
18.8%▼1.0pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
31.8
Price vs earnings
EV/EBITDA
23.4
Enterprise value
FCF Yield
2.8%
Cash generation
Earnings Yield
3.1%
Inverse of P/E
Capital Efficiency
14
GoAI Quality ScoreFair
ROEReturn on Equity
19.3%Strong
ROAReturn on Assets
10.2%Strong
ROICReturn on Invested Capital
12.6%Strong
Financial Health
Current RatioHealthy
1.96
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
0.85x
Debt repayment capacity (<3x)
Income QualityStrong
3.59
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B |
| Gross Profit | $3.64B | $3.54B | $3.46B | $3.72B | $3.41B |
| Gross Margin | 52.4% | 54.3% | 50.7% | 54.4% | 53.9% |
| Operating Income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B |
| Net Income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B |
| Net Margin | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% |
| EPS | $4.59 | $4.44 | $4.22 | $4.19 | $3.98 |
Average Price Target
$165.00▲ 46.3% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Agilent Technologies, Inc., the average price target is $165.00, with a high forecast of $180.00 and a low forecast of $130.00. The average price target represents a 46.3% increase from the current price of $112.75.
Highest
$180.00
Average
$165.00
Lowest
$130.00
Rating Distribution
Strong Buy
1
3%
Buy
28
74%
Hold
8
21%
Sell
1
3%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Morgan Stanley● Maintain
Overweight
2026-03-03Wells Fargo● Maintain
Overweight
2026-02-26Barclays● Maintain
Overweight
2026-02-26UBS● Maintain
Buy
2026-02-26TD Cowen● Maintain
Buy
2026-02-26Evercore ISI Group▲ Upgrade
In Line→Outperform
2026-01-05Barclays▲ Upgrade
Equal Weight→Overweight
2025-12-15UBS● Maintain
Buy
2025-11-25Barclays● Maintain
Equal Weight
2025-11-25Wells Fargo● Maintain
Overweight
2025-11-25Earnings History & Surprises
BEAT RATE
89%
Last 18 quarters
AVG SURPRISE
+3.6%
EPS vs Estimate
BEATS / MISSES
16/1
1 met exactly
LATEST EPS
$1.36
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
-0.7%
$1.36 vs $1.37
Q4 '25
+0.4%
$1.59 vs $1.58
Q3 '25
$1.37 vs $1.37
Q2 '25
+4.0%
$1.31 vs $1.26
Q1 '25
+2.3%
$1.31 vs $1.28
Q4 '24
+3.5%
$1.46 vs $1.41
Q3 '24
+4.8%
$1.32 vs $1.26
Q2 '24
+2.5%
$1.22 vs $1.19
Q1 '24
+5.7%
$1.29 vs $1.22
Q4 '23
+3.0%
$1.38 vs $1.34
Q3 '23
+4.4%
$1.43 vs $1.37
Q2 '23
+0.8%
$1.27 vs $1.26
No investor questions available.
Latest News
No news available